These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23645782)

  • 1. Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer.
    Pesta M; Fichtl J; Kulda V; Topolcan O; Treska V
    Anticancer Res; 2013 May; 33(5):2239-43. PubMed ID: 23645782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly Correlated Recurrence Prognosis in Patients with Metastatic Colorectal Cancer by Synergistic Consideration of Circulating Tumor Cells/Microemboli and Tumor Markers CEA/CA19-9.
    Chu HY; Yang CY; Yeh PH; Hsu CJ; Chang LW; Chan WJ; Lin CP; Lyu YY; Wu WC; Lee CW; Wu JK; Jiang JK; Tseng FG
    Cells; 2021 May; 10(5):. PubMed ID: 34068719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal and Phosphatase of Regenerating Liver-3 Status in Circulating Tumor Cells May Serve as a Crucial Prognostic Marker for Assessing Relapse or Metastasis in Postoperative Patients With Colorectal Cancer.
    Su P; Lai W; Liu L; Zeng Y; Xu H; Lan Q; Chu Z; Chu Z
    Clin Transl Gastroenterol; 2020 Dec; 11(12):e00265. PubMed ID: 33512811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer.
    Aggarwal C; Meropol NJ; Punt CJ; Iannotti N; Saidman BH; Sabbath KD; Gabrail NY; Picus J; Morse MA; Mitchell E; Miller MC; Cohen SJ
    Ann Oncol; 2013 Feb; 24(2):420-428. PubMed ID: 23028040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anterior Approach to Improve the Prognosis in HCC Patients Via Decreasing Dissemination of EpCAM
    Hao S; Chen S; Tu C; Huang T
    J Gastrointest Surg; 2017 Jul; 21(7):1112-1120. PubMed ID: 28378318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumour cells are associated with histopathological growth patterns of colorectal cancer liver metastases.
    Meyer YM; Wilting SM; Kraan J; Olthof P; Vermeulen P; Martens J; Grünhagen DJ; Sleijfer S; Verhoef C
    Clin Exp Metastasis; 2023 Feb; 40(1):69-77. PubMed ID: 36326981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microinvasion of liver metastases from colorectal cancer: predictive factors and application for determining clinical target volume.
    Qian Y; Zeng ZC; Ji Y; Xiao YP
    Radiat Oncol; 2015 Jun; 10():125. PubMed ID: 26040515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and clinical significance of circulating tumour cells in patients with colorectal carcinoma.
    Ihnát P; Srovnal J; Hrubovčák J; Martínek L
    Rozhl Chir; 2023; 102(10):376-380. PubMed ID: 38302423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor cells in melanoma patients.
    Clawson GA; Kimchi E; Patrick SD; Xin P; Harouaka R; Zheng S; Berg A; Schell T; Staveley-O'Carroll KF; Neves RI; Mosca PJ; Thiboutot D
    PLoS One; 2012; 7(7):e41052. PubMed ID: 22829910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro culturing of viable circulating tumor cells of urinary bladder cancer.
    Cegan M; Kolostova K; Matkowski R; Broul M; Schraml J; Fiutowski M; Bobek V
    Int J Clin Exp Pathol; 2014; 7(10):7164-71. PubMed ID: 25400813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative detection of circulating tumor cells predicts tumor recurrence in colorectal cancer patients.
    Galizia G; Gemei M; Orditura M; Romano C; Zamboli A; Castellano P; Mabilia A; Auricchio A; De Vita F; Del Vecchio L; Lieto E
    J Gastrointest Surg; 2013 Oct; 17(10):1809-18. PubMed ID: 23813048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective treatment pressure in colon cancer drives the molecular profile of resistant circulating tumor cell clones.
    Cayrefourcq L; Thomas F; Mazard T; Assenat E; Assou S; Alix-Panabières C
    Mol Cancer; 2021 Feb; 20(1):30. PubMed ID: 33557844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of circulating tumor cells in colorectal cancer with peritoneal metastases: a prospective cohort study using a novel method for monitoring treatment response, and assessing minimal residual disease.
    Frühling P; Moberg L; Ghanipour L; Birgisson H; Graf W; Ericsson C; Cashin PH
    Int J Surg; 2024 Jul; ():. PubMed ID: 38978470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of circulating tumor cells in human metastatic colorectal cancer.
    Barbazán J; Alonso-Alconada L; Muinelo-Romay L; Vieito M; Abalo A; Alonso-Nocelo M; Candamio S; Gallardo E; Fernández B; Abdulkader I; de Los Ángeles Casares M; Gómez-Tato A; López-López R; Abal M
    PLoS One; 2012; 7(7):e40476. PubMed ID: 22811761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase-positive circulating tumor cells are associated with poor prognosis via a neutrophil-mediated inflammatory immune environment in glioma.
    Zhang W; Qin T; Yang Z; Yin L; Zhao C; Feng L; Lin S; Liu B; Cheng S; Zhang K
    BMC Med; 2021 Nov; 19(1):277. PubMed ID: 34763698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An indocyanine green-based liquid biopsy test for circulating tumor cells for pediatric liver cancer.
    Espinoza AF; Kureti P; Patel RH; Do SL; Govindu SR; Armbruster BW; Urbicain M; Patel KR; Lopez-Terrada D; Vasudevan SA; Woodfield SE
    Hepatol Commun; 2024 Jun; 8(6):. PubMed ID: 38727682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of circulating tumour cells in evaluating the efficacy of continuous hepatic arterial infusion among colorectal cancer patients.
    Zhang E; Li H; Liu C; Zhou H; Liu B; Feng C
    J Chemother; 2024 May; ():1-9. PubMed ID: 38711365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic markers and staging systems for patients with colorectal liver metastases.
    Mezhir JJ; D'Angelica MI
    J Gastrointest Surg; 2011 Mar; 15(3):406-9. PubMed ID: 21274751
    [No Abstract]   [Full Text] [Related]  

  • 19. Is the presence of interleukin-2 receptor alpha in the serum of colorectal liver metastases patients derived from hepatic natural killer cells?
    Vermijlen D; Luo D; Kruhøffer M; ØRntoft TF; Kuppen PJ; Wisse E
    Cancer Immunol Immunother; 2002 Jul; 51(5):291-2. PubMed ID: 12070716
    [No Abstract]   [Full Text] [Related]  

  • 20. Circulating Tumor Cells and Thromboembolic Events in Patients with Glioblastoma.
    Rolling CC; Mohme M; Bokemeyer C; Westphal M; Riethdorf S; Lamszus K; Pantel K; Klingler F; Langer F
    Hamostaseologie; 2024 Apr; ():. PubMed ID: 38636546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.